*Department of Pathology, Faculty of Medicine in Pilsen, Charles University
†Bioptic Laboratory Ltd
§Molecular and Genetic Laboratory, Bioptic Laboratory Ltd, Pilsen
∥The Fingerland Department of Pathology, Charles University, Faculty of Medicine and University Hospital Hradec Kralove, Hradec Kralove
††Department of Pathology, 3rd Faculty of Medicine, Charles University and Kralovske Vinohrady University Hospital, Prague
§§Molecular and Genetic Laboratory, South Bohemian University, Ceske Budejovice, Czech Republic
‡Department of Pathology, Friedrich-Alexander University Erlangen-Nürnberg (FAU), University Hospital of Erlangen, Erlangen, Germany
¶Department of Pathology, Warmia nad Mazury University, Olsztyn
#Department of Pathology, Medical University of Gdansk, Gdansk, Poland
**Department of Pathology, University of Parma, Parma, Italy
‡‡Medical Laboratory CSD, Kyiv, Ukraine
∥∥Institute of Biomedicine, University of Turku
¶¶Department of Pathology, Turku University Hospital, Turku, Finland
Preliminary results of the study were presented as a platform presentation at the 109th Annual Meeting of the USCAP, Los Angeles, CA, February 29 to March 5, 2020.
Conflicts of Interest and Source of Funding: Supported in part by study grant SVV 260 539 from the Ministry of Education, Czech Republic and the Finnish Cancer Society, Helsinki, Finland. The authors have disclosed that they have no significant relationships with, or financial interest in, any commercial companies pertaining to this article.
Correspondence: Alena Skálová, MD, PhD, Sikl’s Department of Pathology, Faculty of Medicine in Pilsen, Charles University, E. Benese 13, Pilsen 305 99, Czech Republic (e-mail: [email protected]).